Recent Finacing
Recent Raise
Dispatch Bio's Flare platform uses a viral vector to express a universal tumor antigen that remodels the tumor microenvironment and directs immune recognition and clearance of solid tumor cells.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
